Primary Site >> Colorectal Cancer

Gene >> SLC22A1

Journal: Cancer Res. 2006 Sep 1;66(17):8847-57.
Title: Organic cation transporters are determinants of oxaliplatin cytotoxicity.
Author: Zhang, Shuzhong|Lovejoy, Katherine S|Shima, James E|Lagpacan, Leah L|Shu, Yan|Lapuk, Anna|Chen, Ying|Komori, Takafumi|Gray, Joe W|Chen, Xin|Lippard, Stephen J|Giacomini, Kathleen M
PMID: 16951202
Journal: Cancer Chemother Pharmacol. 2008 Sep;62(4):577-84.
Title: Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.
Author: Kitada, Noriaki|Takara, Kohji|Minegaki, Tetsuya|Itoh, Chihiro|Tsujimoto, Masayuki|Sakaeda, Toshiyuki|Yokoyama, Teruyoshi
PMID: 18030470
Journal: Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):8902-7.
Title: cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects.
Author: Lovejoy, Katherine S|Todd, Ryan C|Zhang, Shuzhong|McCormick, Michael S|D'Aquino, J Alejandro|Reardon, Joyce T|Sancar, Aziz|Giacomini, Kathleen M|Lippard, Stephen J
PMID: 18579768
Journal: J Biol Chem. 2011 Jan 7;286(1):450-9.
Title: Oct1 is a switchable, bipotential stabilizer of repressed and inducible transcriptional states.
Author: Shakya, Arvind|Kang, Jinsuk|Chumley, Jeffrey|Williams, Matthew A|Tantin, Dean
PMID: 21051540
Journal: Cell Cycle. 2013 Dec 1;12(23):3681-8.
Title: Genetic polymorphisms potentially associated with response to metformin in postmenopausal diabetics suffering and not suffering with cancer.
Author: Berstein, Lev M|Iyevleva, Aglaya G|Vasilyev, Dmitry|Poroshina, Tatyana E|Imyanitov, Evgeny N
PMID: 24145224
Journal: PLoS One. 2015 Jul 21;10(7):e0133743.
Title: Esters of Bendamustine Are by Far More Potent Cytotoxic Agents than the Parent Compound against Human Sarcoma and Carcinoma Cells.
Author: Huber, Stefan|Huettner, Johannes Philip|Hacker, Kristina|Bernhardt, Gunther|Konig, Jorg|Buschauer, Armin
PMID: 26196503
Journal: PLoS One. 2016 Feb 9;11(2):e0148739.
Title: Assessment of the Relation between the Expression of Oxaliplatin Transporters in Colorectal Cancer and Response to FOLFOX-4 Adjuvant Chemotherapy: A Case Control Study.
Author: Le Roy, Bertrand|Tixier, Lucie|Pereira, Bruno|Sauvanet, Pierre|Buc, Emmanuel|Petorin, Caroline|Dechelotte, Pierre|Pezet, Denis|Balayssac, David
PMID: 26859833
Journal: Nucleic Acid Ther. 2016 Apr;26(2):111-7.
Title: Lack of Interactions Between an Antisense Oligonucleotide with 2'-O-(2-Methoxyethyl) Modifications and Major Drug Transporters.
Author: Yu, Rosie Z|Warren, Mark S|Watanabe, Tanya|Nichols, Brandon|Jahic, Mirza|Huang, Jane|Burkey, Jennifer|Geary, Richard S|Henry, Scott P|Wang, Yanfeng
PMID: 26959999
Journal: Br J Cancer. 2017 Sep 26;117(7):965-973.
Title: Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228).
Author: Levi, Francis|Karaboue, Abdoulaye|Saffroy, Raphael|Desterke, Christophe|Boige, Valerie|Smith, Denis|Hebbar, Mohamed|Innominato, Pasquale|Taieb, Julien|Carvalho, Carlos|Guimbaud, Rosine|Focan, Christian|Bouchahda, Mohamed|Adam, Rene|Ducreux, Michel|Milano,
PMID: 28817838
Journal: Metallomics. 2018 Mar 1;10(3):414-425.
Title: Relevance of copper transporter 1 and organic cation transporters 1-3 for oxaliplatin uptake and drug resistance in colorectal cancer cells.
Author: Buss, I|Hamacher, A|Sarin, N|Kassack, M U|Kalayda, G V
PMID: 29417972